Delivery Order SPE2DB22D1106-SPE2DB24FDRC1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,294.87, is a Firm Fixed Price Delivery Order for the supply of ABRAXANE 100 MG VIALS, a specialty oncology medication. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,535.30 firm-fixed-price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,240.98 firm fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract, a delivery order valued at $2,727.68, is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. The award has a firm fixed price pricing structure and an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,603.48 firm fixed-price delivery order is for the supply of Abraxane 100 mg vials, a specialty medication. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,288.39 firm fixed price contract is for the supply of ABRAXANE 100 MG vials, a specialty oncology medication. The award has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ABRAXANE 100 MG VIALS. The contract has a ceiling value of $35,702.00 and runs through September 28, 2023. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
- This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCUWG, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,603.41 firm fixed-price delivery order is for the supply of ABRAXANE 100 MG VIALS, with a performance period through March 13, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $4,748.28 firm fixed price delivery order is for 100 milligram vials of the drug ABRAXANE. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceuticals, medical supplies, and related distribution...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDRC1Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,292.38, is for the delivery of ABRAXANE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of December 19, 2023 and is a firm fixed price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.3k | 12/18/23 |